A recently released memo from the Food and Drug Administration (FDA) is drawing scrutiny over the agency's decision to authorize fruit-flavored e-cigarettes, suggesting these products were not demonstrably more effective than tobacco-flavored options in helping adult smokers quit traditional cigarettes. The FDA's authorization last month marked the first time the agency approved fruit-flavored vapes, positioning them as a less harmful alternative to combustible cigarettes.
The decision has faced swift condemnation from health organizations and lawmakers, who have demanded further explanation. The FDA memo, released this week, outlines the agency's reasoning and acknowledges limitations in the data provided by the manufacturer, Glas Inc. To gain FDA approval, e-cigarette companies must prove their products benefit public health by aiding adult smokers in quitting or reducing cigarette use while not appealing to underage individuals.
According to the memo, a study involving smokers who used Glas vapes showed a higher likelihood of complete switching from cigarettes over three months. However, the data did not establish "statistically significant differences" between users of the company's mango and blueberry flavors and those using a tobacco-flavored e-cigarette. This contrasts with previous FDA authorizations for products like Juul's menthol vapes and NJOY's menthol offerings, which demonstrated significant reductions in cigarette use compared to tobacco-flavored vapes.
FDA regulators stated that the Glas flavored vapes did not require a demonstration of